ONC financials
BeOne Medicines (ONC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ONC income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $5.34B | $4.67B | $447.14M | $286.93M | 32.11 |
| 2024 | $3.81B | $3.22B | -$568.20M | -$644.79M | -6.12 |
| 2023 | $2.46B | $2.08B | -$1.21B | -$881.71M | -8.45 |
| 2022 | $1.42B | $1.13B | -$1.79B | -$2.00B | -19.37 |
| 2021 | $1.18B | $1.01B | -$1.44B | -$1.46B | -15.21 |
| 2020 | $308.87M | $238.22M | -$1.66B | -$1.62B | -19.11 |
- ONC revenue was $5.34B in fiscal 2025, net income $286.93M.
Updated 2026-11-07 11:55 UTC